Status | Study |
Not yet recruiting |
Study Name: Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China Condition: Hyperphosphatemia Date: 2016-12-20 Interventions: Drug: Placebo |
Recruiting |
Study Name: A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis Condition: Hyperphosphatemia Date: 2016-11-11 Interventions: Drug: EOS789 Drug: Placebo |
Recruiting |
Study Name: Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia Condition: Hyperphosphatemia Date: 2016-07-14 Interventions: Drug: Nicotinic Acids Nicotini |
Completed |
Study Name: Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia Condition: Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia Date: 2016-03-03 Interventions: Drug: ASP1585 Oral Other Names: |
Recruiting |
Study Name: An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia Condition: Hyperphosphatemia Date: 2016-02-17 Interventions: Drug: PA21 (Velphoro®) |
Recruiting |
Study Name: Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) Condition: Hyperphosphatemia Date: 2016-02-09 Interventions: Drug: sucroferric oxyhydroxide The non-interventional design allows the observation of patients in a bro |
Completed |
Study Name: An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD) Condition: Hyperphosphatemia Date: 2016-02-03 Interventions: Drug: Tenapanor Other Name: RD |
Recruiting |
Study Name: Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients Condition: Hyperphosphatemia End-stage Renal Disease Date: 2016-01-28 Interventions: Other: enhanced individualised therapy |
Completed |
Study Name: Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan Condition: Chronic Kidney Disease Hyperphosphatemia Undergoing Hemodialysi Date: 2015-07-08 Interventions: Drug: ASP3325 oral |
Completed |
Study Name: Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease Condition: Hyperphosphataemia Date: 2014-05-28 Interventions: Drug: PT20 Modified ferric oxi |